All Comments by

  1. Nikolaos K. Robakis on Carnosine, a protective, anti-ageing peptide?
  2. Paul Coleman on Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs.
  3. Benjamin Wolozin on Substitution of a glycogen synthase kinase-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling.
  4. Hiroshi Mori on Expression profiles of multiple genes in single neurons of Alzheimer's disease.
  5. Benjamin Wolozin on Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase.
  6. Hiroshi Mori on Structural analysis of Alzheimer's beta(1-40) amyloid: protofilament assembly of tubular fibrils.
  7. Paul Coleman on Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment.
  8. Hiroshi Mori on Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid beta peptides. Inability of truncated forms of PS2 with familial Alzheimer's disease mutation to increase secretion of Abeta42.
  9. John Hardy on Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.
  10. Paul Coleman on Aloys Alzheimer, a coworker of Emil Kraepelin.
  11. Nikolaos K. Robakis on Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.
  12. Hiroshi Mori on The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
  13. Hiroshi Mori on Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
  14. Hiroshi Mori on Inhibition of Alzheimer beta-fibrillogenesis by melatonin.
  15. Hiroshi Mori on Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes.